Promoting axonal myelination for improving neurological recovery in spinal cord injury

Journal of Neurotrauma

Volumn 26, Issue 10, 2009, Pages 1847-1856

  Wu, Bo ^a,b   Ren, Xianjun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b 88th Hospital   (China)

Author keywords

Cell transplantation; Demyelination; Oligodendrocyte; Remyelination; Spinal cord injury

Indexed keywords

APOPTOSIS; CELL SURVIVAL; CONVALESCENCE; CORD BLOOD STEM CELL TRANSPLANTATION; DEMYELINATION; HUMAN; MYELIN SHEATH; MYELINATION; NERVE CELL NECROSIS; NERVE FIBER; NERVE FUNCTION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REVIEW; SPINAL CORD INJURY; TREATMENT INDICATION; WHITE MATTER;

APOPTOSIS; AXONS; CELL SURVIVAL; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE REGENERATION; OLIGODENDROGLIA; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 70450195802     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0551     Document Type: Review

References (74)

1. Abe, Y., Yamamoto, T., Sugiyama, Y., Watanabe, T., Saito, N., Kayama, H., and Kumagai, T. (1999). Apoptotic cells associated with wallerian degeneration after experimental spinal cord injury: a possible mechanism of oligodendroglial death. J. Neurotrauma 16, 945-952.
2. Akiyama, Y., Radtke, C., Honmou, O., and Kocsis, J.D. (2002). Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39, 229-236.
3. Azari, M.F., Profyris, C., Karnezis, T., Bernard, C.C., Small, D.H., Cheema, S.S., Ozturk, E., Hatzinisiriou, I., and Petratos, S. (2006). Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J. Neuropathol. Exp. Neurol. 65, 914-929.
4. Bambakidis, N.C., and Miller, R.H. (2004). Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. J. Spine 4, 16-26.
5. Barnett, S.C., and Riddell, J.S. (2007). Olfactory ensheathing cell transplantation as a strategy for spinal cord repair-what can it achieve? Nat. Clin. Pract. Neurol. 3, 152-161.
6. Bartolomei, J.C., and Greer, C.A. (2000). Olfactory ensheathing cells: bridging the gap in spinal cord injury. Neurosurgery 47, 1057-1069.
7. Beattie, M.S., Farooqui, A.A., and Bresnahan, J.C. (2000). Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915-925.
8. Blight, A.R. (1983). Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 10, 521-543.
9. Blight, A.R. (1985). Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent. Nerv. Syst. Trauma 2, 299-315.
10. Blight, A.R. (1992). Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9(Suppl 1) S83-S91.
11. Bunge, R.P. (1994). Clinical implications of recent advances in neurotrauma research, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman, and A.I. Faden (eds), Oxford University Press: New York, pps. 329-339.
12. Bunge, R.P., Puckett, W.R., and Hiester, E.D. (1997). Observations on the pathology of several types of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries. Adv. Neurol. 72, 305-315.
13. Cao, Q., Zhang, Y.P., Iannotti, C., DeVries, W.H., Xu, X.M., Shields, C.B., Whittemore, S.R. (2005). Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 191 (Suppl 1), S3-S16.
14. Casha, S., Yu, W.R., and Fehlings, M.G. (2001). Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103, 203-218.
15. Crowe, M.J., Bresnahan, J.C., Shuman, S.L., Masters, J.N., and Beattie, M.S. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
16. Dasari, V.R., Spomar, D.G., Gondi, C.S., Sloffer, C.A., Saving, K.L., Gujrati, M., Rao, J.S., and Dinh, D.H. (2007). Axonal remyelination by cord blood stem cells after spinal cord injury. J. Neurotrauma 24, 391-410.
17. Dimitrijevic, M.R., Faganel, J., Lehmkuhl, D., and Sherwood, A. (1983). Motor control in man after partial or complete spinal cord injury. Adv. Neurol. 39, 915-926.
18. Dong, H., Fazzaro, A., Xiang, C., Korsmeyer, S.J., Jacquin, M.F., and McDonald, J.W. (2003). Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed wallerian degeneration. J. Neurosci. 23, 8682-8691.
19. Emery, E., Aldana, P., Bunge, M.B., Puckett, W., Srinivasan, A., Keane, R.W., Bethea, J., and Levi, A.D. (1998). Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89, 911-920.
20. Fehlings, M.G., and Nashmi, R. (1995). Assessment of axonal dysfunction in an in vitro model of acute compressive injury to adult rat spinal cord axons. Brain. Res. 677, 291-299.
21. Griffiths, I. Anderson T., Klugmann, M., Anderson, T., Yool, D., Thomson, C. Schwab, M.H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., and Nave, K.A. (1998). Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280, 1610-1613.
22. Griffiths, I.R., and McCulloch, M.C. (1983). Nerve fibres in spinal cord impact injuries. Part 1. Changes in the myelin sheath during the initial 5 weeks. J. Neurol. Sci. 58, 335-349.
23. Guest J.D., Hiester, E.D., and Bunge, R.P. (2005). Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192, 384-394.
24. Helgren, M.E., and Goldberger, M.E. (1993). The recovery of postural reflexes and locomotion following low thoracic hemisection in adult cats involves compensation by undamaged primary afferent pathways. Exp. Neurol. 123, 17-34.
25. Hisahara, S., Araki, T., Sugiyama, F., Yagami, K., Suzuki, M., Abe, K., Yamamura, K., Miyazaki, J., Momoi, T., Saruta, T., Bernard, C.C., Okano, H., and Miura, M. (2000). Targeted expression of baculovirus p35 caspase inhibitor in ogliodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J. 19, 341-348.
26. Hulsebosch, C.E. (2002). Recent advances in pathophysiology and treatment of spinal cord injury. Adv. Physiol. Educ. 26, 238-255.
27. Jiang, S., Khan, M.I., Lu, Y., Wang, J., Buttigieg, J., Werstiuk, E.S., Ciccarelli, R., Caciagli, F., and Rathbone, M.P. (2003). Guanosine promotes myelination and functional recovery in chronic spinal injury. NeuroReport 14, 2463-2467.
28. Jones, T.B., McDaniel, E.E., and Popovich, P.G. (2005). Inflammatory- mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11, 1223-1236.
29. Kakulas, B.A. (1999). A review of the neuropathology of human spinal cord injury with emphasis on special features. J. Spinal Cord Med. 22, 119-124.
30. Kakulas, B.A. (1984). Pathology of spinal injuries. Cent. Nerv. Syst. Trauma 1, 117-129.
31. Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Morshead, C.M., and Fehlings, M.G. (2006). Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 26, 3377-3389.
32. Keirstead, H.S., Nistor, G., Bernal, G., Totoiu, M., Cloutier, F., Sharp, K., and Steward, O. (2005). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694-4705.
33. Kerr, B.J., and Patterson, P.H. (2005). Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 51, 73-79.
34. Knoblach, S.M., Huang, X., VanGelderen, J., CalvaCerqueira, D.M., and Faden, A.I. (2005). Selective caspase activation may contribute to neurological dysfunction after experimental spinal cord trauma. J. Neurosci. Res. 80, 369-380.
35. Kocsis, J.D., Akiyama, Y., Lankford, K.L., and Radtke, C. (2002). Cell transplantation of peripheral-myelin-forming cells to repair the injured spinal cord. J. Rehabil. Res. Dev. 39, 287-298. (Pubitemid 34627426)
36. Koda, M., Murakami, M., Ino, H., Yoshinaga, K., Ikeda, O., Hashimoto, M., Yamazaki, M., Nakayama, C., and Moriya, H. (2002). Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats. J. Neurotrauma 19, 777-785.
37. Lampert, P.W., and Cressman, M.R. (1966). Fine-structural changes of myelin sheaths after axonal degeneration in the spinal cord of rats. Am. J. Pathol. 49, 1139-1155.
38. Lee, K.H., Yoon, D.H., Park, Y.G., and Lee, B.H. (2005). Effects of glial transplantation on functional recovery following acute spinal cord injury. J. Neurotrauma 22, 575-589.
39. Liu, X.Z., Xu, X.M., Hu, R., Du, C., Zhang, S.X., McDonald, J.W., Dong, H.X., Wu, Y.J., Fan, G.S., Jacquin, M.F., Hsu, C.Y., and Choi, D.W. (1997). Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406.
40. McDonald, J.W., and Belegu, V. (2006). Demyelination and remyelination after spinal cord injury. J. Neurotrauma 23, 345-359.
41. McDonald, J.W., and Sadowsky, C. (2002). Spinal-cord injury. Lancet 359, 417-425.
42. McEwen, M.L., and Springer, J.E. (2005). A mapping study of caspase-3 activation following acute spinal cord contusion in rats. J. Histochem. Cytochem. 53, 809-819.
43. Morell, P., Quarles, R.H., and Norton, W.T. (1994). Myelin formation, structure and biochemistry, in: Basic Neurochemistry. G.J. Siegel, B.W. Agranoff, R.W. Albers, and P.B. Molinoff (eds), Raven Press: New York, pps. 117-143.
44. Norenberg, M.D., Smith, J., and Marcillo, A. (2004). The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 21, 429-440.
45. Nottingham, S., Knapp, P., and Springer, J. (2002). FK506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury. Exp. Neurol. 177, 242-251.
46. Papastefanaki, F., Chen, J., Lavdas, A.A., Thomaidou, D., Schachner, M., and Matsas, R. (2007). Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain 130, 2159-2174.
47. Peters, A., Palay, S., and Webster, H.D.F. (1991). The Fine Structure of the Nervous System: The Neuron and the Supporting Cells. Oxford University Press: Oxford, pps. 1-494.
48. Popovich, P.G., and Jones, T.B. (2003). Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24, 13-17.
49. Profyris, C., Cheema, S.S., Zang, D., Azari, M.F., Boyle, K., and Petratos, S. (2004). Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 15, 415-436.
50. Raineteau, O., and Schwab, M.E. (2001). Plasticity of motor systems after incomplete spinal cord injury. Nat. Rev. Neurosci. 2, 263-273.
51. Rosenbluth, J., Schiff, R., Liang, W.L., Menna, G., and Young, W. (1997). Xenotransplantation of transgenic oligodendrocytelineage cells into spinal cord injured adult rats. Exp. Neurol. 147, 172-182.
52. Sanchez, I., Hassinger, L., Paskevich, P.A., Shine, H.D., and Nixon, R.A. (1996). Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J. Neurosci. 16, 5095-5105.
53. Santos Benito, F.F., and Ramon Cueto, A. (2003). Olfactory ensheathing glia transplantation: a therapy to promote repair in the mammalian central nervous system. Anat. Rec. B. New. Anat. 271, 77-85.
54. Sasaki, M., Lankford, K.L., Zemedkun, M., and Kocsis, J.D. (2004). Identified olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J. Neurosci. 24, 8485-8493.
55. Schwab, M.E. (2002). Repairing the injured spinal cord. Science 295, 1029-1031.
56. Sekhon, L.H., and Fehlings, M.G. (2001). Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26, S2-S12.
57. Shepherd, G.M. (1988). Neurobiology. Oxford University Press: New York, pps. 689-697.
58. Shi, R., Kelly, T.M., and Blight, A.R. (1997). Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp. Neurol. 148, 495-501.
59. Shuman, S.L., Bresnahan, J.C., and Beattie, M.S. (1997). Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 50, 798-808.
60. Slaets, H., Dumont, D., Vanderlocht, J., Noben, J.P., Leprince, P., Robben, J., Hendriks, J., Stinissen, P., and Hellings, N. (2008). Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and upregulation of 14-3-3. Proteomics 8, 1237-1247.
61. Smith, P.M., and Jeffery, N.D. (2006). Histological and ultrastructural analysis of white matter damage after naturallyoccurring spinal cord injury. Brain Pathol. 16, 99-109.
62. Stirling, D.P., Khodarahmi, K., Liu, J., McPhail, L.T., McBride, C.B., Steeves, J.D., Ramer, M.S., and Tetzlaff, W. (2004). Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24, 2182-2190.
63. Tamura, M., Nakamura, M., Ogawa, Y., Toyama, Y., Miura, M., and Okano, H. (2005). Targeted expression of anti-apoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury. Glia 51, 312-321.
64. Teng, Y.D., Choi, H., Onario, R.C., Zhu, S., Desilets, F.C., Lan, S., Woodard, E.J., Snyder, E.Y., Eichler, M.E. and Friedlander, R.M. (2004). Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 101, 3071-3076.
65. Totoiu, M.O., and Keirstead, H.S. (2005). Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 486, 373-383.
66. Utzschneider, D.A., Archer, D.R., Kocsis, J.D., Waxman, S.G., and Duncan, I.D. (1994). Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc. Natl. Acad. Sci. U.S.A. 91, 53-57.
67. Vos, J.P., Gard, A.L., and Pfeiffer, S.E. (1996). Regulation and oligodendrocyte cell survival and differentiation by ciliary neurotrophic factor, leukemia inhibitory factor oncostatin M, and interleukin-6. Perspect. Dev. Neurobio. 4, 39-52.
68. Warden, P., Bamber, N.I., Li, H., Esposito, A., Ahmad, K.A., Hsu, C.Y., and Xu, X.M. (2001). Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats. Exp. Neurol. 168, 213-224.
69. Waxman, S.G. (1997). Axon-glia interactions: building a smart nerve fiber. Curr. Biol. 7, 406-410.
70. Waxman, S.G. (1992). Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery? J. Neurotrauma. (9 Suppl 1), S105-S117.
71. Windebank, A.J., Wood, P., Bunge, R.P., and Dyck, P.J. (1985). Myelination determines the caliber of dorsal root ganglion neurons in culture. J. Neurosci. 5, 1563-1569.
72. Xu, G.Y., Hughes, M.G., Ye, Z., Hulsebosch, C.E., and McAdoo, D.J. (2004). Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp. Neurol. 187, 329-336.
73. Young, W. (1988). Recovery mechanisms in spinal cord injury: implications for regenerative therapy, in: Neural Regeneration and Transplantation. F.J. Seil (ed), Alan R. Liss: New York, pps. 157-169.
74. Yune, T.Y., Lee, J.Y., Jung, G.Y., Kim, S.J., Jiang, M.H., Kim, Y.C., Oh, Y.J., Markelonis, G.J., and Oh, T.H. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 27, 7751-7761.